Identification of Potential Serum Protein Biomarkers and Pathways for Pancreatic Cancer Cachexia Using an Aptamer-Based Discovery Platform

SIMPLE SUMMARY: Patients with pancreatic cancer and other advanced cancers suffer from progressive weight loss that reduces treatment response and quality of life and increases treatment toxicity and mortality. Effective interventions to prevent such weight loss, known as cachexia, require molecular...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Autores principales: Narasimhan, Ashok, Shahda, Safi, Kays, Joshua K., Perkins, Susan M., Cheng, Lijun, Schloss, Katheryn N. H., Schloss, Daniel E. I., Koniaris, Leonidas G., Zimmers, Teresa A.
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7765482/
https://ncbi.nlm.nih.gov/pubmed/33334063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12123787
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares